Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate (vol 43, pg 699, 2023)

Luis Fein, Nicolas Lazaretti, Yamil Lopez Chuken, J. Rogelio Gonzalez Ramirez Benfield, Max S. Mano, Jose Lobaton, Ernesto Korbenfeld,Fernanda Damian, Dongrui R. Lu,Ave Mori, Shem J. Patyna,Sandra Franco

CLINICAL DRUG INVESTIGATION（2023）

引用 0|浏览0